Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
A sustained passion for performance.
The founders of Quorum Review IRB believed that an IRB did not have to sacrifice customer service to provide a thorough review. They knew they must build a high-performance IRB. So in 1992, that’s what they set out to do. Since then, Quorum has relentlessly pursued better ways to deliver IRB services—for research participants, sponsors and CROs alike.
At Quorum, performance is in our DNA, and throughout our history, we’ve innovated to simplify and streamline for participants, sites and sponsors alike.
Quorum is the IRB of choice when performance matters, and to us it always does.
Schulman IRB and Chesapeake IRB have merged to create Advarra, the premier provider of IRB, IBC and global research compliance services. By integrating our innovative technology and proven regulatory expertise, Advarra helps ensure the highest standards of human research protections. Advarra supports all research phases across all major therapeutic areas.
We are dedicated to the future of clinical development and to every life it saves.